NCT00383136View on ClinicalTrials.gov

FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or Abciximab

PHASE4CompletedINTERVENTIONAL
Enrollment

692

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Acute Myocardial Infarction
Interventions
DRUG

tirofiban high-bolus dose regimen

bolus of 25 mcg/kg of body weight, followed by 18 hours infusion of 0.15 mcg/kg/min.

DRUG

Abciximab

bolus of 0.25 mg/kg of body weight, followed by 12 hours infusion of 0.125 mcg/kg per minute

Trial Locations (6)

10100

Divisione Di Cardiologia Ii, Ospedale Policlinico Le Molinette, Torino

40100

Divisione Di Cardiologia, Ospedale Maggiore, Bologna

40138

Laboratorio Di Emodinamica, Istituto Di Cardiologia, Azienda Ospedaliera S.Orsola Malpighi, Bologna

41100

Azienda Ospedaliera Universitaria Policlinico, Modena

42100

Divisione Di Cardiologia, Ospedale S.Maria Nuova, Reggio Emilia

47900

Divisione Di Cardiologia, Ospedale Per Gli Infermi, Rimini

All Listed Sponsors
lead

University of Bologna

OTHER

NCT00383136 - FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or Abciximab | Biotech Hunter | Biotech Hunter